Parkinson’s disease is a progressive neurological condition that affects movement and whose symptoms appear and progressively intensify, sometimes manifesting with a minor tremor in one of the hands. Tremor is the most common symptom, but in addition to this, stiffness and slowness of movements are often manifested.

In the first stages of the disease, the facial expression can change, sometimes to the absence of the facial expression, the swaying of the arms while walking can disappear and the speech can become cumbersome.

Even though there is still no cure for Parkinson’s disease, medication can significantly improve symptoms and slow the progression of the disease.

In addition to background medication, neuroprotection is also necessary to ensure the survival of the brain structures responsible for movement.

How do we do that?

Well, Citicoline is a biosynthesis substance that, once it reaches the brain, provides cytidine for neuroprotection, and this mechanism protects the neurons affected by the disease.

Citicoline also provides choline, which stimulates the synthesis of the enzyme necessary to convert Levodopa into dopamine, the neurotransmitter absolutely necessary to combat Parkinson’s.